BIIO (Bionovate Technologies) FCF Margin %: 0.00% (As of Sep. 2021)

What is Bionovate Technologies FCF Margin %?

Bionovate Technologies BIIO FCF Margin % is 0.00% as of Sep. 2021.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Bionovate Technologies's Free Cash Flow for the three months ended in Sep. 2021 was $0.00 Mil. Bionovate Technologies's Revenue for the three months ended in Sep. 2021 was $0.00 Mil. Therefore, Bionovate Technologies's FCF Margin % for the quarter that ended in Sep. 2021 was 0.00%.

As of today, Bionovate Technologies's current FCF Yield % is 0.00%.

The historical rank and industry rank for Bionovate Technologies's FCF Margin % or its related term are showing as below:

BIIO's FCF Margin % is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: -0.22
* Ranked among companies with meaningful FCF Margin % only.

Bionovate Technologies FCF Margin % Related Terms

Bionovate Technologies FCF Margin % Historical Data

* Premium members only.

The historical data trend for Bionovate Technologies's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionovate Technologies FCF Margin % Chart

Bionovate Technologies Annual Data

Trend

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

FCF Margin %

Get a 7-Day Free Trial

220.00

0.00

Bionovate Technologies Quarterly Data
	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21
FCF Margin %	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

BIIO vs ABT, MDT, SYK: FCF Margin % Comparison

For the Medical Devices subindustry, Bionovate Technologies's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bionovate Technologies FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bionovate Technologies's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Bionovate Technologies's FCF Margin % falls into.

Save Embed

Bionovate Technologies FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Bionovate Technologies's FCF Margin for the fiscal year that ended in Jun. 2021 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2021 )	/	Revenue (A: Jun. 2021 )
	=	0	/	0
	=	%

Bionovate Technologies's FCF Margin for the quarter that ended in Sep. 2021 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2021 )	/	Revenue (Q: Sep. 2021 )
	=	0	/	0
	=	%

Frequently Asked Questions Learn more about FCF Margin % →

What does a FCF Margin % of 0.00% mean?

Bionovate Technologies (BIIO) has a FCF Margin % of 0.00% as of Sep. 2021. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Bionovate Technologies and its competitors.

Is Bionovate Technologies' FCF Margin % too high?

Bionovate Technologies' current FCF Margin % is 0.00%.

How does Bionovate Technologies' FCF Margin % compare to ABT and MDT?

Bionovate Technologies' FCF Margin % of 0.00% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good FCF Margin % for a Medical Devices & Instruments company?

A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high FCF Margin % mean?

A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Bionovate Technologies and its competitors. Bionovate Technologies's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Bionovate Technologies stock overvalued right now?

Bionovate Technologies (BIIO) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is FCF Margin % calculated?

FCF Margin % is calculated from a company's financial statements. For Bionovate Technologies (BIIO), the current FCF Margin % is 0.00% as of Sep. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bionovate Technologies Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies COL:DFCC.N0000 COL:CDB.N0000 COL:AEL.N0000 COL:OSEA.N0000 COL:DIPD.N0000 COL:SDB.N0000 COL:LMF.N0000 COL:ACL.N0000 COL:LWL.N0000 COL:TKYO.N0000 ABT MDT SYK EW BSX SZSE:300760 DXCM ZBH STE ALGN

Address 950 W Bannock Street, Boise, ID, USA, 83702

Bionovate Technologies Corp operates in the medical devices and diagnostics sector with a focus on mobile technologies.